Commentary to Merwin SJ, Obis T, Nunez Y, Re DB (2017) Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol [Epub ahead of print]. doi:10.1007/s00204-016-1926-1

Commentary to Merwin SJ, Obis T, Nunez Y, Re DB (2017) Organophosphate neurotoxicity to the... Arch Toxicol (2017) 91:3189–3190 DOI 10.1007/s00204-017-1992-z LETTER TO THE EDITOR, NEWS AND VIEWS Commentary to Merwin SJ, Obis T, Nunez Y, Re DB (2017) Organophosphate neurotoxicity to the voluntary motor system on the trail of environment‑caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol [Epub ahead of print]. doi:10.1007/s00204‑016‑1926‑1 1 2 Marcello Lotti · Angelo Moretto Received: 8 May 2017 / Accepted: 16 May 2017 / Published online: 24 May 2017 © Springer-Verlag Berlin Heidelberg 2017 Merwin et al. (2017) discuss in the archives about the disease. On the contrary, striking differences in all clinical hypothesis that a better understanding of amyotrophic aspects of these disorders deserve attention, particularly lateral sclerosis (ALS) may benefit from that of when the intention is that to suggest common/similar delayed polyneuropathy occurring after high doses of mechanisms and models. The El Escorial criteria of the organophosphorus esters (OPIDP). The starting points World Federation of Neurology (Acosta et al. 2015), for the hypothesis include some epidemiological studies reviews (Mitchell and Borasio 2007; Kiernan et al. 2011) linking ALS with organophosphates (OPs) exposures, the and textbooks (Aminoff et al. 2005) indicating the criteria clinical features of ALS that are thought to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Toxicology Springer Journals

Commentary to Merwin SJ, Obis T, Nunez Y, Re DB (2017) Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol [Epub ahead of print]. doi:10.1007/s00204-016-1926-1

Loading next page...
 
/lp/springer_journal/commentary-to-merwin-sj-obis-t-nunez-y-re-db-2017-organophosphate-e4K7iYynNt
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Pharmacology/Toxicology; Occupational Medicine/Industrial Medicine; Environmental Health; Biomedicine, general
ISSN
0340-5761
eISSN
1432-0738
D.O.I.
10.1007/s00204-017-1992-z
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial